Page last updated: 2024-11-03

pyrimethamine and Leishmaniasis, Cutaneous

pyrimethamine has been researched along with Leishmaniasis, Cutaneous in 2 studies

Maloprim: contains above 2 cpds

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adam, I1
Hagelnur, AA1
NEAL, RA1

Trials

1 trial available for pyrimethamine and Leishmaniasis, Cutaneous

ArticleYear
Artesunate plus sulfamethoxypyrazine/pyrimethamine for the treatment of cutaneous leishmaniasis: a double-blind, placebo-controlled clinical trial.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Anti-Infective Agents; Antiprotozoal Agents; Artemisinins; Artesunate; Child; Dou

2009

Other Studies

1 other study available for pyrimethamine and Leishmaniasis, Cutaneous

ArticleYear
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
    Annals of tropical medicine and parasitology, 1964, Volume: 58

    Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyrib

1964